In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

被引:0
作者
Li Qian
Yu Huang
C. Ian Spencer
Amy Foley
Vasanth Vedantham
Lei Liu
Simon J. Conway
Ji-dong Fu
Deepak Srivastava
机构
[1] Gladstone Institute of Cardiovascular Disease,Department of Pediatrics
[2] University of California,Department of Biochemistry and Biophysics
[3] University of California,Department of Medicine
[4] Cardiovascular Research Institute,undefined
[5] University of California,undefined
[6] University of California,undefined
[7] Developmental Biology and Neonatal Medicine Research Program,undefined
[8] Indiana University School of Medicine,undefined
来源
Nature | 2012年 / 485卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The reprogramming of adult cells into pluripotent cells or directly into alternative adult cell types holds great promise for regenerative medicine. We reported previously that cardiac fibroblasts, which represent 50% of the cells in the mammalian heart, can be directly reprogrammed to adult cardiomyocyte-like cells in vitro by the addition of Gata4, Mef2c and Tbx5 (GMT). Here we use genetic lineage tracing to show that resident non-myocytes in the murine heart can be reprogrammed into cardiomyocyte-like cells in vivo by local delivery of GMT after coronary ligation. Induced cardiomyocytes became binucleate, assembled sarcomeres and had cardiomyocyte-like gene expression. Analysis of single cells revealed ventricular cardiomyocyte-like action potentials, beating upon electrical stimulation, and evidence of electrical coupling. In vivo delivery of GMT decreased infarct size and modestly attenuated cardiac dysfunction up to 3 months after coronary ligation. Delivery of the pro-angiogenic and fibroblast-activating peptide, thymosin β4, along with GMT, resulted in further improvements in scar area and cardiac function. These findings demonstrate that cardiac fibroblasts can be reprogrammed into cardiomyocyte-like cells in their native environment for potential regenerative purposes.
引用
收藏
页码:593 / 598
页数:5
相关论文
共 73 条
[1]  
Murry CE(2008)Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development Cell 132 661-680
[2]  
Keller G(2008)Stem-cell-based therapy and lessons from the heart Nature 453 322-329
[3]  
Passier R(2006)Potential of stem-cell-based therapies for heart disease Nature 441 1097-1099
[4]  
van Laake LW(2006)Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 663-676
[5]  
Mummery CL(2007)Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 861-872
[6]  
Srivastava D(2010)Nuclear reprogramming to a pluripotent state by three approaches Nature 465 704-712
[7]  
Ivey KN(2010)Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors Cell 142 375-386
[8]  
Takahashi K(2010)Direct conversion of human fibroblasts to multilineage blood progenitors Nature 468 521-526
[9]  
Yamanaka S(2010)Direct conversion of fibroblasts to functional neurons by defined factors Nature 463 1035-1041
[10]  
Takahashi K(2008) reprogramming of adult pancreatic exocrine cells to β-cells Nature 455 627-632